RapiGen Donates 70,000 COVID-19 Self-Testing Kits to Suwon City

[Suwon Ilbo=Reporter Jung Jun-sung] RapiGen Co., Ltd., a specialized manufacturer of in vitro diagnostic medical devices, donated 70,000 COVID-19 self-testing kits to Suwon Metropolitan City.

Park Jae-gu, CEO of RapiGen, and Director Pyo Myeong-su visited Suwon City Hall on the 22nd and delivered self-testing kits to Suwon Mayor Lee Jae-jun.

The city plans to distribute the self-testing kits to infection-vulnerable facilities with high risk of COVID-19 cluster infections, including disability welfare facilities, elderly welfare facilities, and mental rehabilitation facilities.

RapiGen donated 50,000 self-testing kits to Suwon City in May 2022, and has been consistently practicing sharing by contributing 50 million won to two single-parent family welfare facilities in Suwon last December.

Park Jae-gu, CEO of RapiGen, stated, "We hope the COVID-19 self-testing kits will be helpful in disease prevention."

Mayor Lee Jae-jun said, "We are concerned about cluster outbreaks at infection-vulnerable facilities due to COVID-19 resurgence, and we are grateful to RapiGen for donating self-testing kits necessary for disease prevention. We will respond proactively so that those using infection-vulnerable facilities can conduct early diagnosis with self-testing kits without visiting medical institutions."

RapiGen is the 7th company attracted to Suwon City since the launch of the 8th civilian government. It signed an investment agreement on the 8th.

Established in 2002, RapiGen Co., Ltd. is a specialized in vitro diagnostic medical device company that possesses core technologies in the in vitro diagnostic kits and diagnostic technology fields. It was the first domestic company to develop the "COVID-19 Antigen Self-Testing Kit" that received official product approval from the Ministry of Food and Drug Safety. Its major products include in vitro diagnostic kits (COVID-19, pregnancy tests, etc.) and masks.